nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acetaminophen and Experimental Acute Myocardial Infarction
|
Hale, Sharon L. |
|
2004 |
18 |
2 |
p. 121-125 |
artikel |
2 |
Acetaminophen and Experimental Acute Myocardial Infarction
|
Sharon L. Hale |
|
2004 |
18 |
2 |
p. 121-125 5 p. |
artikel |
3 |
A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET)
|
Cleland, John G.F. |
|
2004 |
18 |
2 |
p. 139-152 |
artikel |
4 |
A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET)
|
John G.F. Cleland |
|
2004 |
18 |
2 |
p. 139-152 14 p. |
artikel |
5 |
Cost-Effectiveness of Primary Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure
|
Lei Chen |
|
2004 |
18 |
2 |
p. 161-170 10 p. |
artikel |
6 |
Cost-Effectiveness of Primary Implanted Cardioverter Defibrillator for Sudden Death Prevention in Congestive Heart Failure
|
Chen, Lei |
|
2004 |
18 |
2 |
p. 161-170 |
artikel |
7 |
Different Effects of Exercise on Plasma Concentrations of Nebivolol, Bisoprolol and Carvedilol
|
Kurt Stoschitzky |
|
2004 |
18 |
2 |
p. 135-138 4 p. |
artikel |
8 |
Different Effects of Exercise on Plasma Concentrations of Nebivolol, Bisoprolol and Carvedilol
|
Stoschitzky, Kurt |
|
2004 |
18 |
2 |
p. 135-138 |
artikel |
9 |
Do Pharmacological Differences Among Beta-Blockers Affect Their Clinical Efficacy in Heart Failure
|
Andrea Di Lenarda |
|
2004 |
18 |
2 |
p. 91-93 3 p. |
artikel |
10 |
Do Pharmacological Differences Among Beta-Blockers Affect Their Clinical Efficacy in Heart Failure?
|
Di Lenarda, Andrea |
|
2004 |
18 |
2 |
p. 91-93 |
artikel |
11 |
ICD's in Congestive Heart FailureIs There Bang for the Beat
|
Thomas D. Szucs |
|
2004 |
18 |
2 |
p. 95-98 4 p. |
artikel |
12 |
ICD’s in Congestive Heart Failure—Is There Bang for the Beat?
|
Szucs, Thomas D. |
|
2004 |
18 |
2 |
p. 95-98 |
artikel |
13 |
Increasing Awareness and Perception of Heart Failure in Europe and Improving Care—Rationale and Design of the SHAPE Study
|
Remme, Willem |
|
2004 |
18 |
2 |
p. 153-159 |
artikel |
14 |
Increasing Awareness and Perception of Heart Failure in Europe and Improving CareRationale and Design of the SHAPE Study
|
Willem Remme |
|
2004 |
18 |
2 |
p. 153-159 7 p. |
artikel |
15 |
Myocardial Protection from Either Ischaemic Preconditioning or Nicorandil Is Not Blocked by Gliclazide
|
Maddock, Helen L. |
|
2004 |
18 |
2 |
p. 113-119 |
artikel |
16 |
Myocardial Protection from Either Ischaemic Preconditioning or Nicorandil Is Not Blocked by Gliclazide
|
Helen L. Maddock |
|
2004 |
18 |
2 |
p. 113-119 7 p. |
artikel |
17 |
Nitric Oxide Synthase (NOS) Does Not Contribute to Simulated Ischaemic Preconditioning in an Isolated Rat Cardiomyocyte Model
|
Hans Strijdom |
|
2004 |
18 |
2 |
p. 99-112 14 p. |
artikel |
18 |
Nitric Oxide Synthase (NOS) Does Not Contribute to Simulated Ischaemic Preconditioning in an Isolated Rat Cardiomyocyte Model
|
Strijdom, Hans |
|
2004 |
18 |
2 |
p. 99-112 |
artikel |
19 |
Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism
|
Ebrahim, Z. |
|
2004 |
18 |
2 |
p. 127-134 |
artikel |
20 |
Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism
|
Z. Ebrahim |
|
2004 |
18 |
2 |
p. 127-134 8 p. |
artikel |
21 |
Reactive Oxygen Species and Cardiac Preconditioning: Many Questions Remain
|
Stowe, David F. |
|
2004 |
18 |
2 |
p. 87-90 |
artikel |
22 |
Reactive Oxygen Species and Cardiac Preconditioning Many Questions Remain
|
David F. Stowe |
|
2004 |
18 |
2 |
p. 87-90 4 p. |
artikel |